Melanoma, version 4.2014.
Publication
, Journal Article
Coit, DG; Thompson, JA; Andtbacka, R; Anker, CJ; Bichakjian, CK; Carson, WE; Daniels, GA; Daud, A; Dimaio, D; Fleming, MD; Gonzalez, R; Ho, M ...
Published in: J Natl Compr Canc Netw
May 2014
The NCCN Guidelines for Melanoma provide multidisciplinary recommendations for the management of patients with melanoma. These NCCN Guidelines Insights highlight notable recent updates. Dabrafenib and trametinib, either as monotherapy (category 1) or combination therapy, have been added as systemic options for patients with unresectable metastatic melanoma harboring BRAF V600 mutations. Controversy continues regarding the value of adjuvant radiation for patients at high risk of nodal relapse. This is reflected in the category 2B designation to consider adjuvant radiation following lymphadenectomy for stage III melanoma with clinically positive nodes or recurrent disease.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
May 2014
Volume
12
Issue
5
Start / End Page
621 / 629
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Melanoma
- Humans
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Coit, D. G., Thompson, J. A., Andtbacka, R., Anker, C. J., Bichakjian, C. K., Carson, W. E., … National Comprehensive Cancer Network, . (2014). Melanoma, version 4.2014. J Natl Compr Canc Netw, 12(5), 621–629. https://doi.org/10.6004/jnccn.2014.0066
Coit, Daniel G., John A. Thompson, Robert Andtbacka, Christopher J. Anker, Christopher K. Bichakjian, William E. Carson, Gregory A. Daniels, et al. “Melanoma, version 4.2014.” J Natl Compr Canc Netw 12, no. 5 (May 2014): 621–29. https://doi.org/10.6004/jnccn.2014.0066.
Coit DG, Thompson JA, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, et al. Melanoma, version 4.2014. J Natl Compr Canc Netw. 2014 May;12(5):621–9.
Coit, Daniel G., et al. “Melanoma, version 4.2014.” J Natl Compr Canc Netw, vol. 12, no. 5, May 2014, pp. 621–29. Pubmed, doi:10.6004/jnccn.2014.0066.
Coit DG, Thompson JA, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daniels GA, Daud A, Dimaio D, Fleming MD, Gonzalez R, Guild V, Halpern AC, Hodi FS, Kelley MC, Khushalani NI, Kudchadkar RR, Lange JR, Martini MC, Olszanski AJ, Ross MI, Salama A, Swetter SM, Tanabe KK, Trisal V, Urist MM, McMillian NR, Ho M, National Comprehensive Cancer Network. Melanoma, version 4.2014. J Natl Compr Canc Netw. 2014 May;12(5):621–629.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
May 2014
Volume
12
Issue
5
Start / End Page
621 / 629
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- Melanoma
- Humans
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis